GlassScriptPhysician profile
Michelle Santoyo
NPI 1760612550
$630.46
in general payments reported to CMS, 2019-2025
14 companies · $172 in 2025
The $172 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48.48 · 2020: $12.80 · 2021: $36.36 · 2022: $203 · 2023: $131 · 2024: $27.53 · 2025: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $330.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $329.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $157.67 | 2025 | Myosure Tissue Removal Device, Coolseal Generator |
| Scynexis, INC. | $95.10 | 2022 | |
| Evofem Biosciences, INC. | $68.33 | 2020-2023 | Phexxi |
| Avion Pharmaceuticals | $55.66 | 2022-2023 | Balcoltra |
| Abbvie INC. | $42.97 | 2019-2023 | Lo Loestrin Fe |
| Myovant Sciences INC. | $40.68 | 2022 | |
| Coopersurgical, INC. | $36.44 | 2021-2022 | |
| Sage Therapeutics, LLC | $27.53 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.89 | 2023 | |
| Sumitomo Pharma America, INC. | $21.59 | 2023 | Myfembree |
| Lupin INC. | $15.97 | 2019 | |
| Mayne Pharma Commercial LLC | $15.41 | 2022 | |
| Mission Pharmacal Company | $15.37 | 2019 | |
| Davol INC. | $13.85 | 2025 | Arista |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Santoyo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.